Saphenous vein graft lesions: Are second‐generation drug‐eluting stents better?. Issue 1 (1st January 2016)

• Record Type: Journal Article
• Authors: Kolte, Dhaval; Dawn Abbott, J.
• Is Part Of: Catheterization and cardiovascular interventions. Volume 87:Issue 1(2016)
• Page Start: 41
• Page End: 42
• Publication Date: 2016-01-01
• Subjects: Heart -- Diseases -- Diagnosis -- Periodicals; Cardiac catheterization -- Periodicals; 616.1207572
• DOI: 10.1002/ccd.26390
• Languages: English
• ISSNs: 1522-1946

Abstract

Key Points: Long‐term outcomes were similar in patients treated with first‐ or second‐generation drug‐eluting stents (DES) for saphenous vein graft (SVG) lesions. Patients presenting with acute myocardial infarction as a result of occluded SVG may derive some benefit from the use of second‐ versus first‐generation DES Randomized clinical trials are needed to determine whether newer DES types including those with bioabsorbable polymer or scaffolds offer a distinct advantage in the treatment of SVG lesions.